Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0037 | 0.0083 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0037 | 0.0083 | 0.0083 |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0524 | 0.6994 | 0.6994 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0037 | 0.0083 | 0.5 |
Leishmania major | calcium channel protein, putative,ion transporter, putative | 0.0079 | 0.0693 | 0.0614 |
Loa Loa (eye worm) | TKL/RAF/RAF protein kinase | 0.0241 | 0.2983 | 0.2983 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0049 | 0.026 | 0.026 |
Leishmania major | ferric reductase, putative | 0.0246 | 0.3052 | 0.2993 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0037 | 0.0083 | 0.0149 |
Brugia malayi | Blistered cuticle protein 3 | 0.0524 | 0.6994 | 0.6994 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.0262 | 0.3285 | 0.3285 |
Loa Loa (eye worm) | hypothetical protein | 0.0217 | 0.265 | 0.265 |
Loa Loa (eye worm) | beta-lactamase | 0.0037 | 0.0083 | 0.0083 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0097 | 0.094 | 0.094 |
Brugia malayi | beta-lactamase family protein | 0.0037 | 0.0083 | 0.0083 |
Trypanosoma brucei | ferric reductase transmembrane protein, putative | 0.0246 | 0.3052 | 0.2993 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0083 | 0.0083 |
Echinococcus granulosus | sodium channel protein | 0.0079 | 0.0693 | 0.0693 |
Loa Loa (eye worm) | hypothetical protein | 0.024 | 0.2971 | 0.2971 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0735 | 1 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.024 | 0.2971 | 0.2971 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0172 | 0.2005 | 0.6004 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0083 | 0.0083 |
Onchocerca volvulus | 0.0049 | 0.026 | 0.0255 | |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0262 | 0.3285 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0037 | 0.0083 | 0.0083 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0262 | 0.3285 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0233 | 0.2878 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0262 | 0.3285 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0505 | 0.0505 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0735 | 1 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0049 | 0.026 | 0.0464 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0172 | 0.2005 | 0.6004 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0262 | 0.3285 | 0.3285 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0172 | 0.2005 | 0.6004 |
Brugia malayi | Raf kinase | 0.041 | 0.5383 | 0.5383 |
Onchocerca volvulus | Dual oxidase homolog | 0.0524 | 0.6994 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.0505 | 0.0903 |
Echinococcus multilocularis | sodium channel protein | 0.0079 | 0.0693 | 0.0693 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0066 | 0.0505 | 0.0505 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0097 | 0.094 | 0.094 |
Mycobacterium ulcerans | beta-lactamase | 0.0037 | 0.0083 | 0.5 |
Brugia malayi | hypothetical protein | 0.024 | 0.2971 | 0.2971 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0735 | 1 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0037 | 0.0083 | 0.5 |
Schistosoma mansoni | sterol O-acyltransferase 1 | 0.0241 | 0.2983 | 0.5334 |
Toxoplasma gondii | ABC1 family protein | 0.0037 | 0.0083 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0037 | 0.0083 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0097 | 0.094 | 0.094 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0172 | 0.2005 | 0.6004 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0172 | 0.2005 | 0.6004 |
Echinococcus multilocularis | raf serine:threonine protein kinase | 0.0425 | 0.5593 | 0.5593 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0262 | 0.3285 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0735 | 1 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.0037 | 0.0083 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0172 | 0.2005 | 0.6004 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0262 | 0.3285 | 1 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0735 | 1 | 1 |
Loa Loa (eye worm) | raf kinase | 0.0423 | 0.5563 | 0.5563 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0083 | 0.0083 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0037 | 0.0083 | 0.0083 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0083 | 0.0083 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0037 | 0.0083 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0278 | 0.3508 | 0.3508 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.024 | 0.2971 | 0.2971 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0172 | 0.2005 | 0.2781 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0037 | 0.0083 | 0.0083 |
Echinococcus granulosus | voltage gated sodium channel Nav1 alpha subunit | 0.0079 | 0.0693 | 0.0693 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.026 | 0.0464 |
Trypanosoma cruzi | ferric reductase transmembrane protein, putative | 0.0246 | 0.3052 | 0.2993 |
Mycobacterium leprae | conserved hypothetical protein | 0.0037 | 0.0083 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0735 | 1 | 1 |
Echinococcus granulosus | sterol O acyltransferase 1 | 0.0241 | 0.2983 | 0.2983 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0083 | 0.0083 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0262 | 0.3285 | 1 |
Brugia malayi | beta-lactamase | 0.0037 | 0.0083 | 0.0083 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0181 | 0.2137 | 0.6415 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0037 | 0.0083 | 0.0083 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0735 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0181 | 0.2137 | 0.6415 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.2983 | 0.2983 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0083 | 0.0083 |
Treponema pallidum | hypothetical protein | 0.007 | 0.0561 | 0.5 |
Echinococcus multilocularis | sterol O acyltransferase 1 | 0.0241 | 0.2983 | 0.2983 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0172 | 0.2005 | 0.6004 |
Echinococcus granulosus | raf serine:threonine protein kinase | 0.0425 | 0.5593 | 0.5593 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0735 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0425 | 0.5593 | 1 |
Trypanosoma cruzi | ferric reductase transmembrane protein, putative | 0.0246 | 0.3052 | 0.2993 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.094 | 0.094 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0735 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0735 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.007 | 0.0561 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0735 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0037 | 0.0083 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.06 ug ml-1 | Antibacterial activity against Enterococcus faecalis NCTC 6013 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.12 ug ml-1 | Antibacterial activity against Bacillus subtilis ATCC 6051 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Staphylococcus aureus ATCC 6538p after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Staphylococcus epidermidis ATCC 14940 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Escherichia coli NCTC 12900 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Salmonella typhi ATCC 19430 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Shigella flexneri NCTC 8516 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 0.5 ug ml-1 | Antibacterial activity against Escherichia coli NCTC 12900 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 1 ug ml-1 | Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | = 1 ug ml-1 | Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | > 4 ug ml-1 | Antibacterial activity against Serratia marcescens PTCC 1111 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | > 4 ug ml-1 | Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 18 hrs | ChEMBL. | 17316916 |
MIC (functional) | > 4 ug ml-1 | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs | ChEMBL. | 17316916 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.